Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Tricarbonyl 99mTc(i) and Re(i)–thiosemicarbazone complexes: synthesis, characterization and biological evaluation for targeting bacterial infection
Dipak Kumar Nayak
a,
Rinku Baishyaa,
Ramalingam Natarajanb,
Tuhinadri Senc and
Mita Chatterjee Debnath*a
aInfectious Disease and Immunology Division, Indian Institute of Chemical Biology (CSIR), 4, Raja S. C. Mullick Road, Jadavpur, Kolkata-700032, India. E-mail: mita_chdebnath@yahoo.com; mitacd@iicb.res.in; Fax: +91 33-2473-5197; Fax: +91 33-2472-3967; Tel: +91 33-2473 3491
bChemistry Division, Indian Institute of Chemical Biology (CSIR), 4, Raja S. C. Mullick Road, Jadavpur, Kolkata-700032, India
cDepartment of Pharmaceutical Technology, Jadavpur University, Kolkata-700032, India
First published on 16th December 2025
Abstract
Correction for ‘Tricarbonyl 99mTc(i) and Re(i)–thiosemicarbazone complexes: synthesis, characterization and biological evaluation for targeting bacterial infection’ by Dipak Kumar Nayak et al., Dalton Trans., 2015, 44, 16136–16148, https://doi.org/10.1039/c5dt02264a.
Fig. 8 in the original article inadvertently included a duplicate image for 99mTc(CO)3-2 at 4 and 8 h. The corrected figure for 8 h is replaced here.
 | ||
| Fig. 8 Scintigraphic images of 99mTc(CO)3–thiosemicarbazone in S. aureus infected rats at 4 h and 8 h post-injection (i.v.): (I) 99mTc(CO)3-1, (II) 99mTc(CO)3-2, (III) 99mTc(CO)3-3. | ||
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2026 |